PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Stem cell type resists chemotherapy drug

Stem cell type resists chemotherapy drug
2014-07-02
(Press-News.org) PROVIDENCE, R.I. [Brown University] — A new study shows that adipose-derived human stem cells, which can become vital tissues such as bone, may be highly resistant to the common chemotherapy drug methotrexate (MTX). The preliminary finding from lab testing may prove significant because MTX causes bone tissue damage in many patients.

MTX is used to treat cancers including acute lymphoblastic leukemia, the most common form of childhood cancer. A major side effect of the therapy, however, is a loss of bone mineral density. Other bone building stem cells, such as bone marrow derived stem cells, have not withstood MTX doses well.

"Kids undergo chemotherapy at such an important time when they should be growing, but instead they are introduced to this very harsh environment where bone cells are damaged with these drugs," said Olivia Beane, a Brown University graduate student in the Center for Biomedical Engineering and lead author of the study. "That leads to major long-term side effects including osteoporosis and bone defects. If we found a stem cell that was resistant to the chemotherapeutic agent and could promote bone growth by becoming bone itself, then maybe they wouldn't have these issues."

Stem cell survivors

Originally Beane was doing much more basic research. She was looking for chemicals that could help purify adipose-derived stem cells (ASCs) from mixed cell cultures to encourage their proliferation. Among other things, she she tried chemotherapy drugs, figuring that maybe the ASCs would withstand a drug that other cells could not. The idea that this could help cancer patients did not come until later.

In the study published online in the journal Experimental Cell Research, Beane exposed pure human ASC cultures, "stromal vascular fraction" (SVF) tissue samples (which include several cell types including ASCs), and cultures of human fibroblast cells, to medically relevant concentrations of chemotherapy drugs for 24 hours. Then she measured how those cell populations fared over the next 10 days. She also measured the ability of MTX-exposed ASCs, both alone and in SVF, to proliferate and turn into other tissues.

Beane worked with co-authors fellow center member Eric Darling, the Manning Assistant Professor in the Department of Molecular Pharmacology, Physiology and Biotechnology, and research assistant Vera Fonseca.

They observed that three chemotherapy drugs — cytarabine, etoposide, and vincristine — decimated all three groups of cells, but in contrast to the fibroblast controls, the ASCs withstood a variety of doses of MTX exceptionally well (they resisted vincristine somewhat, too). MTX had little or no effect on ASC viability, cell division, senescence, or their ability to become bone, fat, or cartilage tissue when induced to do so.

The SVF tissue samples also withstood MTX doses well. That turns out to be significant, Darling said, because that's the kind of tissue that would actually be clinically useful if an ASC-based therapy were ever developed for cancer patients. Hypothetically, fresh SVF could be harvested from the fat of a donor, as it was for the study, and injected into bone tissue, delivering ASCs to the site.

To understand why the ASCs resist MTX, the researchers conducted further tests. MTX shuts down DNA biosynthesis by binding the protein dihydrofolate reductase so that it is unavailable to assist in that essential task. The testing showed that ASCs ramped up dihydrofolate reductase levels upon exposure to the drug, meaning they produced enough to overcome a clinically relevant dose of MTX.

Toward a therapy?

Now that the researchers are aware of ASC's ability to resist MTX, they are eager to see if they can make progress toward delivering a medical benefit for cancer patients. They plan several more experiments.

One is to test ASC survival and performance after 48- and 72-hour exposures to MTX. Another is to begin examining how the cells fare in mouse models of chemotherapy. They also plan to directly compare ASCs and bone marrow-derived stem cells amid various chemotherapies.

Darling said his team hopes it can make a contribution by helping patients heal from chemotherapy, which does what it must, but at a cost.

"The first step is to save a life," he said. "Chemotherapies do a great job of killing cells and killing the cancer, and that's what you want. But then there is a stage after that where you need to do recovery and regeneration."

Further research will reveal whether stem cells can be part of that process.

INFORMATION: The National Institutes of Health (grants R01AR063642, P20GM104937) and the National Science Foundation (CBET1253189) supported the research.

[Attachments] See images for this press release:
Stem cell type resists chemotherapy drug

ELSE PRESS RELEASES FROM THIS DATE:

Hollow optical fibers for UV light

Hollow optical fibers for UV light
2014-07-02
This news release is available in German. If you want to send light on a trip through optical fibres with as little loss as possible, you should opt for infrared light, as is the case, for example, in the telecommunication networks worldwide. For certain applications, such as spectroscopic investigations on ions or atoms, however, (laser) light in the ultraviolet range is required. But this type of light would quickly damage conventional optical fibres. Researchers from the Max Planck Institute for the Science of Light (MPL) in Erlangen/Germany and of the QUEST Institute, ...

Inspired by nature, researchers create tougher metal materials

2014-07-02
Drawing inspiration from the structure of bones and bamboo, researchers have found that by gradually changing the internal structure of metals they can make stronger, tougher materials that can be customized for a wide variety of applications – from body armor to automobile parts. "If you looked at metal under a microscope you'd see that it is composed of millions of closely-packed grains," says Yuntian Zhu, a professor of materials science and engineering at NC State and senior author of two papers on the new work. "The size and disposition of those grains affect the ...

Behavioral therapy in pediatric antidepressant treatment reduces likelihood of relapse

Behavioral therapy in pediatric antidepressant treatment reduces likelihood of relapse
2014-07-02
DALLAS – July 2, 2014 – Cognitive behavioral therapy in addition to medication improves the long-term success of treatment for children and adolescents suffering from depression, a new UT Southwestern Medical Center study indicates. Based on the results of a clinical trial conducted at UT Southwestern and Children's Medical Center of Dallas, depression relapse rates were substantially lower in a group of youth who received both forms of treatment versus medication alone. "Continuation-phase strategies designed to reduce the high rates of relapse in depressed youths ...

Harnessing a personal rivalry can boost an individual's athletic performance

2014-07-02
July 2, 2014 - We can all think of great sports rivals: tennis players Andre Agassi and Pete Sampras, swimmers Michael Phelps and Ryan Lochte, or basketball players Magic Johnson and Larry Bird. These fierce, personal rivalries seem worlds apart from a hometown 5K race. Yet even local races often produce rivals who push each other to higher levels of performance, according to new research that surveyed runners and used data from 184 races. Rivalries are distinct from other competitions as those involved place higher stakes on their performance independent of any tangible ...

Twin study links community socioeconomic deprivation to sleep duration

Twin study links community socioeconomic deprivation to sleep duration
2014-07-02
DARIEN, IL – A new study of adult twins suggests that the level of socioeconomic deprivation in a neighborhood is associated with the sleep duration of residents. Results show that increased socioeconomic deprivation was significantly associated with decreased sleep duration across all twins. Further analysis within twin pairs found that this association remained significant after accounting for genetics and shared family environment, indicating a robust relationship. "These results are a starting point for discussing the impact that neighborhood-level factors have ...

The dark side of Twitter -- Infidelity, break-ups, and divorce

The dark side of Twitter -- Infidelity, break-ups, and divorce
2014-07-02
New Rochelle, NY, July 2, 2014—With more than 554 million active users, Twitter is one of the most popular social networking sites. Active users of social networking who are in a romantic relationship may find that Twitter-related conflicts cause relationship problems that can become serious enough to result in infidelity or divorce, as described in a study published in Cyberpsychology, Behavior, and Social Networking , a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Cyberpsychology, Behavior, and Social Networking ...

Causes of serious pain syndrome closer to discovery

2014-07-02
Researchers at the University of Liverpool have taken a major step forward in understanding the causes of a disorder which causes chronic pain in sufferers. Complex Regional Pain Syndrome (CRPS) is a serious condition affecting a limb after an – often small – accident or operation. It can cause severe pain lasting many years, as well as limb swelling, hair and nail growth changes, and muscle atrophy, but until now there has been no clear evidence of the cause. Now the research team from the University's Institute of Translational Medicine alongside colleagues at the ...

Upending a cancer dogma

Upending a cancer dogma
2014-07-02
Researchers at the University of California, San Diego School of Medicine say a protein essential to regulating cell cycle progression – the process of cell division and replication – activates a key tumor suppressor, rather than inactivating it as previously thought. "The finding is the result of literally 20 years of work in my lab," said Steven F. Dowdy, PhD, professor in the Department of Cellular and Molecular Medicine at UC San Diego. "It completely turns upside-down what was thought to be a fundamental aspect of cell cycle progression in all cancer cells driven ...

Deforestation remedies can have unintended consequences, UF researchers say

2014-07-02
GAINESVILLE, Fla. --- When it comes to fixing deforestation and forest degradation, good intentions can lead to bad outcomes. That's the take-away from a new study by two University of Florida researchers who say efforts to restore damaged and destroyed tropical forests can go awry if the people making the plans of action don't choose wisely. "We need to be careful about what is it we're losing and gaining," UF biology professor Francis E. "Jack" Putz said. Putz worked with UF biology professor Claudia Romero on the paper, which will appear in the July issue of Biotropica. ...

Antibiotic therapy reduces mortality by 68 percent in hemodialysis patients

Antibiotic therapy reduces mortality by 68 percent in hemodialysis patients
2014-07-02
DETROIT – An antibiotic therapy known to reduce catheter-related bloodstream infections in hemodialysis patients has been shown for the first time to reduce mortality, according to a Henry Ford Health System study. Researchers found that a low-dose "lock" solution of gentamicin/citrate reduced mortality by 68 percent compared to a solution of heparin, a blood-clotting therapy long considered the standard of care. Additionally, the gentamicin/citrate solution was associated with a 73 percent reduction in bloodstream infections compared to the heparin treatment. Bloodstream ...

LAST 30 PRESS RELEASES:

Exercise as an anti-ageing intervention to avoid detrimental impact of mental fatigue

UMass Amherst Nursing Professor Emerita honored as ‘Living Legend’

New guidelines aim to improve cystic fibrosis screening

Picky eaters by day, buffet by night: Butterfly, moth diets sync to plant aromas

Pennington Biomedical’s Dr. Leanne Redman honored with the E. V. McCollum Award from the American Society for Nutrition

CCNY physicists uncover electronic interactions mediated via spin waves

Researchers’ 3D-printing formula may transform future of foam

Nurture more important than nature for robotic hand

Drug-delivering aptamers target leukemia stem cells for one-two knockout punch

New study finds that over 95% of sponsored influencer posts on Twitter were not disclosed

New sea grant report helps great lakes fish farmers navigate aquaculture regulations

Strain “trick” improves perovskite solar cells’ efficiency

How GPS helps older drivers stay on the roads

Estrogen and progesterone stimulate the body to make opioids

Dancing with the cells – how acoustically levitating a diamond led to a breakthrough in biotech automation

Machine learning helps construct an evolutionary timeline of bacteria

Cellular regulator of mRNA vaccine revealed... offering new therapeutic options

Animal behavioral diversity at risk in the face of declining biodiversity

Finding their way: GPS ignites independence in older adult drivers

Antibiotic resistance among key bacterial species plateaus over time

‘Some insects are declining but what’s happening to the other 99%?’

Powerful new software platform could reshape biomedical research by making data analysis more accessible

Revealing capillaries and cells in living organs with ultrasound

American College of Physicians awards $260,000 in grants to address equity challenges in obesity care

Researchers from MARE ULisboa discover that the European catfish, an invasive species in Portugal, has a prolonged breeding season, enhancing its invasive potential

Rakesh K. Jain, PhD, FAACR, honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research

Solar cells made of moon dust could power future space exploration

Deporting immigrants may further shrink the health care workforce

Border region emergency medical services in migrant emergency care

Resident physician intentions regarding unionization

[Press-News.org] Stem cell type resists chemotherapy drug